Skip to content
The Department of Neurology has a long and dynamic legacy of promoting diversity and inclusion in the workplace and health care setting.
Contact our scheduling team to make an in-person or Virtual Visit appointment
Learn about our Adult Neurology and Child Neurology Residency Programs.
Clinical trials are a key component of the research mission of the Department of Neurology at CUIMC
Showing 1 - 10 of 160 results.
Columbia research seven years in the making highlights potential therapeutic target for neurodegenerative disease
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease.
Please join in welcoming Dr. Sarah O’Shea to the department.
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
High blood pressure in young people may have a negative effect on their brains in midlife, research suggests.
A recent look inside a baby zebrafish's transparent brain offers clues to how we remember and how we forget.
Aphasia affects around 2 million people in the United States, with nearly 180,000 people developing the condition each year.
The Department of Neurology Awards Dr. Andrew B. Lassman 2022 Clinician of the Year.
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.